Literature DB >> 794440

Characterization of measles viruses in establishment of persistent infections in human lymphoid cell line.

T Minagawa, T Sakuma, S Kuwajima, T K Yamamoto, H Iida.   

Abstract

Human lymphoid cells (NC-37) were infected with attenuated measles vaccine virus (Schwarz, AIK-C, and CAM-70 strains), subacute sclerosing panencephalitis virus (Mantooth and Halle strains), neurovirulent TYCSA strain, and wild type virus (Edmonston and Toyoshima strains) at an input multiplicity of 0-01. These strains were divided into two groups by their capacity to establish carrier states. CAM-70, Toyoshima, and Edmonston strains did not set up persistent infections in NC-37 cells, whereas AIK-C strain induced chronic cyclic infection and the Schwarz, TYCSA, Mantooth and Halle strains could set up persistent infections and furthermore two types of persistent infections were recognizable. Cells persistently infected with Schwarz strain contained nucleocapsid structures in both nucleus and cytoplasm, and produced infectious virus of 10(4) to 10(5) p.f.u./ml over 100 days after the inoculation of the virus but the cap-formation of measles antigens on the cell membrane was seldom observed. However, in cells persistently infected with TYCSA strain, nucleocapsid structures were rarely observed in the nucleus, but the cap-formation of measles antigens on the cell membrane was often observed. The titre of carried virus was always higher than the number of cells in the range of 10(6) to 10(7) p.f.u./ml. Mantooth strain was similar to Schwarz strain and Halle strain was similar to TYCSA strain in the properties of their carrier states. These carrier states were stable and the cells grew normally for over one year.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 794440     DOI: 10.1099/0022-1317-33-3-361

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

Review 1.  Measles virus and its associated diseases.

Authors:  E M Morgan; F Rapp
Journal:  Bacteriol Rev       Date:  1977-09

2.  Growth of measles virus in continuous cell lines derived from the nervous tissues of human and rat.

Authors:  K Kobune; K Yamanouchi; Y Yoshikawa; M Hayami; A Shishido
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Relation of HVJ (Sendai virus) production to cell growth phase in persistently infected mouse 3T3 cells.

Authors:  H Ogura; H Sato; M Hatano
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

4.  Expression of bicistronic measles virus P/C mRNA by using hybrid adenoviruses: levels of C protein synthesized in vivo are unaffected by the presence or absence of the upstream P initiator codon.

Authors:  G Alkhatib; B Massie; D J Briedis
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

5.  Characterization of a hamster brain cell line persistently infected with measles virus.

Authors:  R Vainionpää; A Salmi; P Arstila
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Isolation of cold-sensitive mutants of measles virus from persistently infected murine neuroblastoma cells.

Authors:  B Rager-Zisman; J E Egan; Y Kress; B R Bloom
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

7.  Measles virus-specified polypeptide synthesis in two persistently infected HeLa cell lines.

Authors:  S L Wechsler; R Rustigian; K C Stallcup; K B Byers; S H Winston; B N Fields
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

8.  Isolation of a heterogeneous population of temperature-sensitive mutants of measles virus from persistently infected human lymphoblastoid cell lines.

Authors:  G Ju; S Udem; B Rager-Zisman; B R Bloom
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

9.  Evaluation of infectious titer in a candidate HSV type 2 vaccine by a quantitative molecular approach.

Authors:  Ali Azizi; Mei Tang; Lucy Gisonni-Lex; Laurent Mallet
Journal:  BMC Microbiol       Date:  2013-12-06       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.